Baillie Gifford & Co. Cuts Stock Position in Lemonade, Inc. $LMND

Baillie Gifford & Co. lessened its holdings in shares of Lemonade, Inc. (NYSE:LMND) by 5.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,942,056 shares of the company’s stock after selling 168,226 shares during the quarter. Baillie Gifford & Co. owned about 3.98% of Lemonade worth $157,488,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of LMND. Analyst IMS Investment Management Services Ltd. grew its stake in shares of Lemonade by 80.7% during the second quarter. Analyst IMS Investment Management Services Ltd. now owns 571,768 shares of the company’s stock worth $25,049,000 after purchasing an additional 255,368 shares in the last quarter. Halter Ferguson Financial Inc. grew its stake in Lemonade by 101.3% during the 3rd quarter. Halter Ferguson Financial Inc. now owns 575,906 shares of the company’s stock worth $30,828,000 after buying an additional 289,803 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Lemonade by 4.3% during the second quarter. Bank of New York Mellon Corp now owns 160,328 shares of the company’s stock worth $7,024,000 after acquiring an additional 6,646 shares during the last quarter. Titleist Asset Management LLC acquired a new position in Lemonade in the second quarter valued at $203,000. Finally, Jump Financial LLC increased its position in Lemonade by 365.8% in the 2nd quarter. Jump Financial LLC now owns 581,378 shares of the company’s stock valued at $25,470,000 after acquiring an additional 456,571 shares during the period. 80.30% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on LMND. Truist Financial initiated coverage on shares of Lemonade in a research note on Tuesday, January 6th. They set a “buy” rating and a $98.00 price target on the stock. Keefe, Bruyette & Woods lifted their price objective on Lemonade from $35.00 to $40.00 and gave the stock an “underperform” rating in a research report on Tuesday, November 25th. Morgan Stanley set a $85.00 target price on shares of Lemonade and gave the company an “equal weight” rating in a report on Tuesday, December 16th. Citizens Jmp raised their price objective on Lemonade from $60.00 to $80.00 and gave the stock a “market outperform” rating in a report on Monday, November 24th. Finally, Piper Sandler decreased their target price on shares of Lemonade from $60.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. Four research analysts have rated the stock with a Buy rating, two have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $71.50.

Lemonade Stock Performance

LMND opened at $93.10 on Friday. The company has a market capitalization of $6.96 billion, a P/E ratio of -38.95 and a beta of 1.98. Lemonade, Inc. has a 1-year low of $24.31 and a 1-year high of $99.90. The company has a 50-day moving average of $77.82 and a 200-day moving average of $61.44.

Lemonade (NYSE:LMND) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.51) EPS for the quarter, topping analysts’ consensus estimates of ($0.72) by $0.21. Lemonade had a negative net margin of 26.39% and a negative return on equity of 31.86%. The firm had revenue of $194.50 million during the quarter, compared to the consensus estimate of $185.06 million. During the same quarter in the previous year, the company posted ($0.95) earnings per share. The firm’s revenue was up 42.4% on a year-over-year basis. As a group, sell-side analysts expect that Lemonade, Inc. will post -3.03 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Adina Eckstein sold 7,919 shares of the business’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $81.15, for a total transaction of $642,626.85. Following the completion of the transaction, the chief operating officer owned 188,391 shares in the company, valued at $15,287,929.65. The trade was a 4.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Daniel A. Schreiber sold 126,625 shares of the company’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $94.74, for a total transaction of $11,996,452.50. Following the transaction, the chief executive officer owned 1,523,534 shares of the company’s stock, valued at $144,339,611.16. This represents a 7.67% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 306,350 shares of company stock worth $25,870,918. Company insiders own 14.70% of the company’s stock.

More Lemonade News

Here are the key news stories impacting Lemonade this week:

• Positive Sentiment: Strategic Tesla partnership — Lemonade announced a technical collaboration to price miles driven under Tesla FSD with a ~50% discount, which investors view as validation of Lemonade’s data-driven pricing and a potential path to profitable customer acquisition. Lemonade’s Tesla Deal Could Rewrite How Auto Insurance Is Priced
• Positive Sentiment: Product rollout & market reaction — Multiple press pieces highlight Lemonade’s new autonomous‑vehicle insurance for Tesla FSD users and the stock recently hit a multi‑year/52‑week high as investors priced in growth and margin upside from cross‑selling and lower acquisition costs. Insurtech Lemonade Unveils AI‑Driven Insurance for Autonomous Vehicles
• Positive Sentiment: Unusual bullish options flow — Traders bought a material number of call contracts (notable increase vs. average), signalling speculative bullish interest that can amplify moves if the partnership narrative continues to play out.
• Neutral Sentiment: Analyst attention & target resets — Coverage is being refreshed after the Tesla announcement; some analysts are raising targets while others caution gains may be short‑lived unless fundamentals keep improving. How Lemonade Is Rewriting Its Story As Analyst Targets Reset
• Neutral Sentiment: Zacks note on sustainability of the jump — Zacks flagged that heavy volume and estimate revisions drove the recent ~13% jump but warned that the momentum may not immediately extend without follow‑through on estimates. Strength Seen in Lemonade: Can Its 13.1% Jump Turn into More Strength?
• Negative Sentiment: Large insider sales — CEO Daniel Schreiber sold 126,625 shares (~$12.0M at ~$94.74) and another insider (John Sheldon Peters) sold 9,000 shares (~$810k). These sizable, disclosed Form 4 sales can be interpreted as near‑term supply pressure or signal for some investors to take profits. Schreiber SEC Form 4 Peters SEC Form 4
• Negative Sentiment: Execution & regulatory risk — The Tesla product rollout is currently limited and depends on FSD safety metrics and state/regulatory approvals; any setbacks or higher claims could hurt Lemonade’s improved margin story (this is noted in coverage of the deal).

About Lemonade

Lemonade, Inc (NYSE: LMND) is a New York–based technology-driven insurance carrier that leverages artificial intelligence and behavioral economics to streamline the purchase and management of policies. Founded in 2015, the company offers renters, homeowners, pet, term life and car insurance products tailored for digitally savvy consumers. By automating underwriting and claims processing through chatbots and machine learning, Lemonade aims to deliver a more transparent and user-friendly experience than traditional insurers.

The company’s product suite includes standalone policies for renters and homeowners, customizable pet insurance plans, and term life coverage with simple online applications.